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Abstract
Background: Facilitation of the differentiation of the stem cells toward neuronal lineage is crucial for enhancing the
differentiation efficacy of grafted stem cells for the possible treatment of neurodegenerative disorders. MicroRNA124a
(miR-124a) has been considered as a neuronal lineage regulator, possessing the capability to activate neuronal
differentiation. In this study, using a neuronal promoter-based reporter and live-cell fluorescence imaging, we visualized
in vitro and in vivo the enhanced neuronal differentiation of neuronal progenitor cells with miR-124a overproduction.
Methods: The neuron specific alpha1 tubulin promoter-driven RFP reporter (pTa1-RFP) was used to trace the miR-124a-
induced neuronal differentiation in live cell condition. MiR-124a or miR-scramble in 10 % glucose buffer was mixed with
in vivo-jetPEITM and in vivo fluorescence images were obtained daily using Maestro spectral fluorescent imager.
Results: Neurite outgrowth was clearly seen in F11 cells after miR-124a transfection, and immunofluorescence staining
showed increase of Tuj1 and NF at 48 hours. When pTa1-RFP-transfected F11 cells were implanted simultaneously with
miR-124a into the nude mice, gradually increasing reporter signals and morphological changes indicated neuronal
differentiation for 48 hours in live cells in vitro. The miR-124a-treated F11 cells showed higher reporter signals on in vivo
fluorescence imaging than miR-scramble-treated cells, which were verified by ex vivo confirmation of Tuj1 and NF
expression.
Conclusions: These results indicated that neuronal reporter-based neurogenesis imaging can be used for monitoring
miR-124a acting as neuronal activator when miRNA was injected in in vivo PEI-coated form for miRNA-mediated
regenerative therapy.
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Background
For the intractable brain diseases, the feasibility of im-
munotherapy and cell-based therapy have been studied
using primates or small animals [1–3]. Therapeutic strat-
egy using stem or progenitor cells was proposed as a
possibility to treat neurodegenerative disorders replacing
the injured brain tissues with cell implants. Embryonic
stem cells, mesenchymal stem cells, and neural stem or
progenitor cells were proposed as cell candidates [4–7].
Among these cells, neural stem or progenitor cells were
found promising as they are able to differentiate to
neurons if implanted [8–11]. However, though these
stem cells were highly expected to differentiate into
neuronal cells for the success of stem cell treatment, in
reality, they rarely differentiate into the desired cell
lineage when implanted. Thus, investigators used a var-
iety of potential factors to enhance the differentiation
in vivo, such as neurogenin 1 (ngn1), neuroD2 (pro-
neural basic helix-loop-helix transcription factors), or
microRNAs [12–15].
MicroRNAs participate in post-transcriptional regula-
tion of cellular differentiation by binding to the comple-
mentary sequences of target messenger RNAs (mRNAs)
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or non-coding RNAs and down-regulate their target
gene expression. During developmental process, let-7
microRNAs regulate developmental timing or certain
microRNAs are over-expressed or under-expressed in
diseases such as cancer, metabolic diseases, and cardio-
vascular disorders [16–20]. MicroRNAs might be used
as a tool to control the biological process of interest
even for the treatment of neurodegenerative diseases.
Among the variety of microRNAs expressed exclusively
in the nervous system, miR-124a is abundantly expressed
as neuron-specific miRNAs [21–25]. miR-124a was re-
ported to promote neuronal differentiation by triggering
brain-specific alternative pre-mRNA splicing [26–30]
and was known to participate in neuronal fate determin-
ation during spinal cord development [31], and miR-
124a was necessary for a proper brain development and
axogenesis of dentate granule neurons [32]. miR-124a
might be able to promote neuronal differentiation of
stem or progenitor cells when co-administered with the
stem/progenitor cell implants as a differentiation activa-
tor. If proven for its efficacy, injection of miR-124a
might enhance the feasibility of using progenitor cell
implants in intractable neurological disorders.
Reporter genes have been used as molecular-genetic
imaging agents for monitoring various cellular biologic
processes [33–35]. For visualization of neuronal differen-
tiation using molecular imaging techniques, neuron-
specific promoter-driven optical reporters can be used as
simple imaging system to monitor the transition of
implanted stem cells into neuronal lineage in vivo. Tα1,
a member of tubulin, is expressed abundantly during
neuronal development, and Tα1 mRNA is enriched in
neurons undergoing active neurite extension [36, 37]. In
this study, neuron-specific pTα1 promoter-driven RFP
reporter system was adopted to trace the activation of
neuronal differentiation in vitro and in vivo induced by
the administration of exogenous miR-124a in the im-
plants of neural progenitor or stem cells.
Methods
Cell cultures
F11 (hybrid cell line of rat dorsal root ganglion cell with
mouse neuroblastoma) and HB1.F3 (an immortalized,
clonal human neural stem cell line) were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, Invitro-
gen, Grand Island, NY) supplemented with 10 % fetal
bovine serum (FBS, Invitrogen, Grand Island, NY) and
1 % antibiotics (Invitrogen, Grand Island, NY) at 5 %
CO2 atmosphere.
MiRNAs and fluorescence reporter gene transfection
To promote neuronal differentiation by miR-124a, 1 × 105
of F11 or F3 cells were seeded in 12-well plates. After 24-
h incubation, 50 nM of chemically modified miR-124a or
miR-scramble oligomer (Life technologies, Ambion, CA)
was transfected into F11 or F3 cells using a Lipofectamine
reagent (Invitrogen, Grand Island, NY). For a live cell
imaging, 1 × 104 of F11 or F3 cells were seeded in eight-
well chamber slide (Nunc, NY). 0.2 μg of pTα1 (Talpha1
promoter)-RFP (kindly donated by Keejung Yoon, Sun-
gyunkwan University) [38] and miRNA oligomer were co-
transfected into F11 cells using Lipofectamine.
Immunofluorescence imaging and neurite outgrowth
measurement
Cells were fixed with 4 % paraformaldehyde (USB®, OH)
or 20 min at room temperature and incubated in 0.5 %
hydrogen peroxide in methanol for 20 min. After phos-
phate buffered saline (PBS) washing, cells were incubated
in 0.1 % Triton X-100 (Samchum Chemical, Seoul). Thirty
minutes after blocking with 1:30 dilution of normal goat
serum, 1:300 dilution of rabbit neuron-specific class III β-
tubulin (Tuj1; Sigma, MO), 1:500 dilution of rabbit neuro-
filament (NF; Sigma, MO), 1:300 dilution of mouse glial
fibrillary acidic protein (GFAP; Cell Signaling, MA), 1:300
dilution of rabbit enolase-1 (Cell Signaling, MA), and
1:300 dilution of mouse BrdU (Cell signaling, MA),
these samples were incubated for 24 h at 4 °C. After
washing, the cells were incubated for 1 h with 1:400 di-
lution of Alexa Fluor 488 anti-mouse and Alexa Fluor
555 anti-rabbit secondary antibodies (Invitrogen, CA).
Sample slides were prepared with 4′,6-diamidino-2-
phenylindole hydrochloride (DAPI) mounting solution
(Vector Laboratories, CA). Fluorescence images were
obtained, and neurite outgrowths were measured by a
Zeiss 510 Meta Laser scanning microscope (LSM; Carl
Zeiss Microimaging, NY).
Fluorescence live cell imaging of F11 transfected with
miR-124a
For visualizing the activation of neuronal differentiation
induced by the overproduction of miR-124a, 1 × 104 of
F11 cells were seeded in each well of eight-well chamber
slide and co-transfected with miR-124a (40 nM) and
pTα1-RFP (0.2 μg). During 48 h, phase contrast and
fluorescence images were obtained in a time-lapse im-
aging system (Olympus IX81 ZDC microscope, PA).
Each image was obtained simultaneously with every 30-
min intervals.
In vivo fluorescence imaging of neuronal differentiation
of F11 cells co-administered with miR-124a
Seven-week-old male BALB/c nude mice (n = 3) were
used for the in vivo fluorescence imaging and housed
under pathogen-free animal environment. Mice were
handled according to the ethical and biosafety guidelines
issued by the Institutional Animal Care and Use Com-
mittee (IACUC: 2014-0066) of Seoul National University
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Hospital (SNUH). This research was reviewed and finally
approved by SNUH committee with qualified animal
experience and expertise. Firstly, 9 × 106 of pTα1-RFP-
transfected F11 cell pellets were prepared. For the
miRNA transfection, 50 nM of miR-124a or miR-
scramble in 10 % glucose buffer was mixed with in vivo
jetPEI™ (Polyplus-transfection Inc., NY) and incubated
for 15 min at RT. The miRNA-polyethylenimine (PEI)
complexes were mixed with the prepared F11 cell pellets,
and the cells mixed with 150 μl of matrigel (BD Bio-
science, CA) were subcutaneously injected into both
thighs of nude mice (Fig. 1). After the injections, in vivo
fluorescence imaging was daily acquired using Maestro
spectral fluorescent imager (Maestro; Cri Inc., MA). At
4 days, the mice skin was removed and fluorescence
signals from the region of interest (ROI) were quantita-
tively analyzed.
Immunohistochemistry of implanted mass
Implanted mass over the thighs of the nude mice were
excised, and these samples containing F11 cells with miR-
124a or miR-scramble were fixed with 4 % paraformalde-
hyde for 20 min at room temperature. The samples were
embedded in paraffin block, and the paraffin block was
sectioned by a rotary microtome Leica RM2145 (Leica
Microsystems, Wetzlar). Ten-micrometer-thick sectioned
samples were stained with primary antibodies against 1:100
dilution of rabbit RFP (Abcam Inc., MA), 1:300 dilution of
rabbit Tuj1 (Sigma, MO), and 1:500 dilution of rabbit NF
(Sigma, MO) overnight at 4 °C. Then, the samples were in-
cubated with 1:400 dilution of Alexa Fluor 488 anti-mouse
and Alexa Fluor 488 anti-rabbit secondary antibodies for
1 h. The sample slides were prepared with 4′,6-diamidino-
2-phenylindole hydrochloride (DAPI) mounting solution
and fluorescence images were obtained by a Zeiss 510
Meta Laser scanning microscope (LSM; Carl Zeiss
Microimaging, NY).
Results
Morphological changes of F11 cells treated with miR-124a
To confirm the changes of F11 cells by miR-124a in
their morphology toward neuronal characteristics, miR-
124a or miR-scramble was transfected into F11 cells at
24 h after cell seeding. At 24 and 48 h post-transfection,
significant neurite outgrowth was observed in the miR-
124a-transfected group (Fig. 2a). In contrast, miR-
scramble-treated and non-treated group showed no
morphological changes until 2 days.
Enhanced expression of neuronal markers induced by
miR-124a in F11 and F3 cells
To verify the enhanced expression of neuronal markers
of F11 cells induced by the overproduction of miR-124a,
we performed immunofluorescence at 48 h after miR-
124a transfection using neuronal-specific antibodies
Tuj1, NF, enolase, and GFAP. Neuron-specific class III
β-tubulin (Tuj1) is present in newly generated immature
post-mitotic neurons and differentiated neurons and in
some mitotically active neuronal precursors. Neurofila-
ments (NFs) are the intermediate filaments found spe-
cifically in neurons. Tuj1 and NF expressions were
significantly higher in miR-124a-treated F11 cells, com-
pared to miR-scramble-treated cells (Fig. 2b). BrdU
Fig. 1 Schematic display of experimental procedure for miR-124a-induced neurogenesis in vivo. Complexation between negatively charged miR-124a
oligomer and positively charged in vivo PEI polymer was formed at room temperature, and neural progenitor cells were mixed with this pre-formed
complex polymer before cell implantation. Temperature-sensitive matrigel was used to trap the cells within gel scaffold, and this cell/matrigel complex
was implanted into the thighs of nude mice
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staining results showed that the population of proliferating
cells decreased in miR-124a-treated F11 cells suggesting
that miR-124a-induced neuronal differentiation is associ-
ated with the decreased proliferation. Enolase-1 is ubiqui-
tously expressed in adult tissues including the brain and
liver and elevated in neuroblastoma. As a marker of neuro-
blastoma, ubiquitously expressing enolase-1 expression
was intense in both scramble- and miR-124a-treated
F11 cells and glial cell marker GFAP expression was
not found in both groups.
To examine that F3 neural stem cells are also induced
into neuronal cells by miR-124a, the different concentration
of miR-124a (10, 30, and 50 nM) was treated to F3 cells.
Consistent with F11 cells, Tuj1 expression increased in
miR-124a-treated F3 cells in the cytoplasmic region from
10 nM concentration, compared to miR-scramble-treated
cells (Fig. 3).
Time course of F11 cell changes showing neuronal-
lineage differentiation by miR-124a on fluorescence live
cell imaging in vitro
Once we introduced alpha tubulin 1 (pTα1-RFP) reporter
to F11 cells [39] and observed once every 30 min until
48 h after, RFP signals increased gradually in miR-124a-
Fig. 2 Enhanced neuronal gene expression in F11 cells treated with miR-124a. a F11 cells were transfected with miR-124a or miR-scramble oligomer,
respectively. Morphological changes were observed at 24 and 48 h after transfection. MiR-124a-transfected cells showed significant neurite outgrowth,
compared to non-transfected or miR-scramble-transfected cells. Scale bars, 100 μm. b F11 cells transfected with either miR-124a or miR-scramble were
fixed using 4 % paraformaldehyde for 20 min. Antibodies against enolase, Tuj1, NF, and GFAP were used to evaluate the neuronal differentiation stage.
Tuj1 and NF expression increased significantly in miR-124a-transfected F11 cells
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Fig. 3 Activation of neuronal differentiation by miR-124a in F11 and F3 cells. Two days after transfection of different dose of miR-124a/miR-scramble
(10, 30, and 50 nM), immunofluorescence was done using Tuj1 antibody. Tuj1 expression in both F11 and F3 cells was increased from
10 nM concentration of miR-124a oligomer. Treatment of miR-scramble did not induce Tuj1 expression in both F11 and F3 cells
Fig. 4 Neuronal differentiation of F11 cell changes by miR-124a on fluorescence live cell imaging. MiR-124a or miR-scramble was co-transfected
with pTα1-RFP into F11 cells, and the changes of RFP reporter expression were examined every 30 min during 48 h. a RFP signal increased
gradually in F11 cells treated with miR-124a, but not in miR-scramble treated cells. b, c The length of neurite outgrowth in miR-124a-transfected F11
cells was longer than miR-scramble-transfected cells
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treated F11 cells. At 36 h, RFP signals were prominent
along with neurite elongation in the miR-124a-treated
F11 cells (Fig. 4a). The length of neurite outgrowth
was measured by a Zeiss 510 Meta Laser scanning
microscope, and the outgrowth length was much lon-
ger in miR-124a-treated F11 cells than miR-scramble-
treated F11 cells (Fig. 4b, c).
In vivo fluorescence imaging of differentiating F11 cells
induced by co-administration of miR-124a to the implants
After pTα1-RFP-transfected cells were mixed with in
vivo-tailored PEI-coated miR-124a or miR-scramble, the
transfected cells were subcutaneously injected in the left
and right thighs of mice, and in vivo fluorescence images
were acquired daily for 4 days in nude mice. Background
fluorescence was high as soon as the cells were im-
planted (0 day). However, fluorescence signals increased
at 2 and 4 days in the right side where miR-124a was
co-administered (Fig. 5a). After removing the skin at
4 days, fluorescence of the miR-124a-co-administered
side was distinctly higher than that of the miR-scramble-
co-administered side. The semi-quantitative region of
interest (ROI) value revealed the higher fluorescence sig-
nals in miR-124a-treated F11 cell group at 4 days
(Fig. 5b). To verify the neuronal differentiation pattern
of F11 cells by overproduction of miR-124a in vivo, we
isolated F11 cells from injected sites of the mice imme-
diately after sacrifice the mice.
Immunohistochemistry analysis showed that expres-
sion of Tuj1, early neuronal marker and NF, and late
neuronal markers increased in miR-124a-treated F11
cells, compared to those in miR-scramble-treated F11
cells (Fig. 5c).
Discussion
Facilitating the neuronal differentiation from the grafted
stem or progenitor cells is important to enhance thera-
peutic efficacy of the stem cell treatment for a variety of
neurological diseases. There are many types of already
known molecules enhancing neuronal differentiation
such as a chemical compound (retinoic acid, cAMP), ex-
ogenous genes (neuroD2, ngn1), and non-coding RNAs
[12, 13, 40–42]. Several miRNAs have been reported
closely linked to regulating neuronal differentiation in
the development of neurological diseases [43–45]. For
example, the down-regulation of neurogenic miRNAs
such as miR-9 and miR-132 leads to the impaired neuro-
genesis [46, 47]. MiR-124a is well-known as an essential
regulator of neuronal differentiation by down-regulating
the proliferation-related genes [48]. Using miR-124a to
promote neuronal differentiation may be a feasible strat-
egy considering its definite expression difference in
neural progenitor cells between pre-and post-neuronal
differentiation [49, 50]. In addition, several reports
demonstrated that miR-124a itself was sufficient to in-
duce neuronal differentiation, which can even be
regarded as an accelerator to induce neurogenesis [51,
52]. We assumed that the up-regulation of miR-124a ex-
pression increase the neuronal differentiation helping
enhance therapeutic efficacy of stem/progenitor cell im-
plants. If we want to prove this strategy works or not, it
is important to reveal how much of the implanted pro-
genitor cells (or stem cells) differentiate into neuronal
lineage by miR-124a administration and molecular im-
aging method we used worked and was simple and
reliable.
In our results, the immunofluorescence clearly revealed
that miR-124a facilitated the differentiation toward neur-
onal lineage in a short period of time in neural progenitor
F11 or neural stem F3 cells. The early neuronal marker
Tuj1 and late neuronal marker NF levels were definitely
increased in miR-124a-treated F11 cells, showing elabor-
ate neurite formation (Fig. 2b). We also examined the
dynamic time courses of reporter expression representing
neuronal differentiation of F11 cells induced by miR-124a
and live F11 cells provided in vitro their extent of differen-
tiation efficiency. Neuron-like morphological changes of
F11 neuronal progenitor cells after the overexpression of
miR-124a complied with the Tα1 promoter-driven RFP re-
porter gene expression visualizing the neuronal differenti-
ation of these cells [53]. MiR-124a-transfected F11 cells
clearly showed the gradual increase in RFP signals along
with stretched cell body in live cell condition until 2 days
after miR-124a transfection.
For in vivo miR-124a transfection study, we used easily
available in vivo jetPEI™, which is composed of a positive
charged polyethylenimine polymer, and mixed our miR-
124a with this polymer transfection agent [54]. When
RFP-laden F11 cells were co-administered with PEI-miR-
124a complex as an implant into each thigh of nude
mouse, the similarly low RFP signals and excessive auto-
fluorescence signals from the skin were observed both in
miR-124a-treated and miR-scramble-treated side at
0 day. However, the fluorescence intensity in miR-124a-
treated F11 cell group became higher at 4 days, compared
to scramble-treated F11 cell group. In in vivo fluorescence
imaging study in skin-removed mice, visually and quanti-
tatively, the discrepancy of RFP signal between miR-124a-
treated and scramble-treated group became prominent at
4 days. Ex vivo study has also confirmed that the im-
planted F11 cells differentiated to the neuronal lineage by
the influence of miR-124a co-administered mixed with
PEI in vivo. Immunohistochemistry proved the miR-124a-
induced increased expression of Tuj1 and NF in the
isolated section of implanted F11 cells. These finding
demonstrated that exogenous miR-124a oligomer alone,
when co-administered in matrix gel with the cell implants,
induces the neuronal differentiation of F11 cells in nude
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mice. This phenomenon could be examined simply using
in vivo fluorescence imaging technique.
The imaging investigation of the functional outcome
of miRNA co-administration will be helpful for the
evaluation of the possible in vivo effect of various
miRNA or related nucleic acid oligomers (such as siRNA
or gapmer). Some of them might be as a key controller of
a variety of biological phenomenon such as cell differenti-
ation. Though we just proved the effect of single micro-
RNA (miR-124a) in this study, PEI system easily hosts
Fig. 5 In vivo fluorescence imaging in the differentiated F11 cells induced by miR-124a. F11 cells transfected with pTα1-RFP were subcutaneously
inoculated into both thighs of nude mice with matrigel (n = 3). Before injection, F11 cells were mixed with miRNAs (miR-124a or miR-scramble)
coated with in vivo-jetPEI™ solution. a Fluorescence images were daily acquired in individual group up to 4 days. RFP signals in miR-124a-treated
F11 cells were higher in nude mice at 4 days, compared to those in miR-scramble-treated F11 cells. b After the mouse skin was removed at 4 days,
ROI analysis demonstrated higher fluorescence signals in miR-124a-treated cells than miR-scramble-treated cells (n = 3 *p < 0.05). ROI area was
drawn on each injection site. c F11 cells were isolated from the injection sites from the sacrificed nude mice, and immunohistochemistry was
done for RFP and neuronal markers (Tuj1 and NF). MiR-124a-treated F11 cells showed increased RFP, Tuj1, and NF levels, compared with
miR-scramble-treated group
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cocktails of microRNAs. This easy sensing technique to
report miRNA function in vivo will be attractive because
of widespread applicability for elucidating unknown func-
tions of specific miRNA.
Fluorescence-based optical imaging modality has been
widely harnessed to examine time-course changes of
amount of biomolecules with high resolution. Neverthe-
less, the intrinsic shortcoming that cannot acquire the
signals in deep tissue hampers to move forward clinical
application. Much effort has been made to use a longer
NIR wavelength and wavefront shaping technique with
the control of multiple light scattering to overcome
tissue penetration issue [55, 56]. Even though our
fluorescence-based approach to trace the effect of miR-
124a might not give useful information non-invasively in
clinic, this technique could be applied for minimal inva-
sive intraoperative study using multiphoton microscopy
to trace the course of neuronal differentiation by miR-
124a in living brain tissue.
Conclusions
In this study, we imaged the functional outcome of miR-
124a transfection to the stem/progenitor cell implants fo-
cusing on the activating the neuronal differentiation using
neuron-specific promoter-based reporter gene system. In
vitro live cell tracking to trace the dynamic changes of dif-
ferentiation toward neuronal fate by miR-124a would have
also inform us when we can expect the probable changes
of cellular fate after in vivo administration despite the dif-
ference between in vitro and in vivo situation. We suggest
that this approach provides invaluable information to
evaluate functional outcome of cell-based therapy co-
administered with neurogenic miRNAs in a variety of
neurological disease model.
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